GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Bax | affects response to substance | EXP | | 6480464 | CTD | BAX mRNA affects the susceptibility to ciglitazone | PMID:12065618 | Bax | increases expression | EXP | | 6480464 | CTD | ciglitazone results in increased expression of BAX protein | PMID:12065618 | Bax | increases expression | ISO | BAX (Homo sapiens) | 6480464 | CTD | ciglitazone results in increased expression of BAX protein | PMID:15492468 | Bax | multiple interactions | ISO | BAX (Homo sapiens) | 6480464 | CTD | [Niflumic Acid co-treated with ciglitazone] results in increased activity of BAX protein; DDIT3 mutant form inhibits the reaction [[Niflumic Acid co-treated with ciglitazone] results in increased activity of BAX protein] | PMID:21067863 | |
Go Back to source page | Continue to Ontology report |